IRIS
Grimaldi, Luigi Maria Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 184
EU - Europa 44
NA - Nord America 29
SA - Sud America 1
Totale 258
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 131
HK - Hong Kong 49
IT - Italia 22
US - Stati Uniti d'America 16
MX - Messico 13
UA - Ucraina 10
DE - Germania 9
NL - Olanda 2
BR - Brasile 1
CN - Cina 1
ID - Indonesia 1
JP - Giappone 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 258
Salva come PNG Salva come JPEG
Città #
Singapore 80
Hong Kong 44
Mexico City 13
Rome 12
Milan 4
Pescara 2
Florence 1
Izmir 1
Moscow 1
Santa Clara 1
São Paulo 1
Weehawken 1
Totale 161
Salva come PNG Salva come JPEG
Nome #
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial 7
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 6
The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk 6
The molecular anatomy of human Hps60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential patogenetic role of anti-chaperonin immunity in myasthenia gravis 6
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study 5
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 5
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study 5
Multiple Sclerosis Progression and Relapse Activity in Children 5
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective 4
An Italian programme for COVID-19 infection in multiple sclerosis 4
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 4
Silver nitrate staining of unconcentrated cerebrospinal fluid proteins. Clinico-statistical analysis of 53 neurology patients | Colorazione con nitrato d'argento delle proteine del liquido cefalorachidiano non concentrato. Analisi clinico-statistica su 53 pazienti neurologici 4
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 4
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 4
Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register 4
Genetic burden of common variants in progressive and bout-onset multiple sclerosis 4
Interferon-γ induces T lymphocyte proliferation in multiple sclerosis via a Ca2+-dependent mechanism 4
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 4
Association study of the HLA-A2 allele in Italian Alzheimer disease patients 4
γ-interferon activates a new Ca2+ influx in T-lymphocytes from multiple sclerosis patients 4
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis 4
Immunity and the Stiff-man syndrome: Pathogenetic Problems 4
Assessment of brain core temperature using MR DWI-thermometry in Alzheimer disease patients compared to healthy subjects 4
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 4
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial 4
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 4
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 4
Interferon-γ activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosis 3
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 3
Cultures of peripheral lymphocytes of multiple sclerosis patients. Isoelectrophoretic analysis after stimulation with pokeweed mitogen | Colture di linfociti periferici di pazienti con sclerosi multipla. Analisi isoelettroforetica dopo stimolazione con pokeweed mytogen 3
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification 3
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study 3
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 3
Reply 3
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 3
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study) 3
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: A randomised, controlled phase 3 trial 3
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with alzheimers disease: A prospective, observational study 3
L'utilizzo del topo SCID per la creazione di nuovi modelli sperimentali chimerici di miastenia gravis 3
Intracellular Ca2+ stores of T lymphocytes: Changes induced by in vitro and in vivo activation 3
SOLUBLE INTERLEUKIN-1 RECEPTOR ANTAGONIST INTRON 2 POLYMORPHISM: FUNCTIONAL ROLE AND RELEVANCE IN MULTIPLE SCLEROSIS 3
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients 3
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study 3
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension 3
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 3
Natalizumab in pediatric multiple sclerosis: Results of a cohort of 55 cases 3
Restricted heterogeneity of antibody to gp120 and p24 in AIDS 3
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 3
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study 3
Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis 3
APOE ε2-4 and -491 polymorphisms are not associated with MS 3
Oligoclonal IgG and IgA in subacute sclerosing panencephalitis | IgG e IgA oligoclonali nella panencefalite sclerosante subacuta 3
Randomized trial of daily high-dose Vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a 3
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 3
Signs and symptoms of COVID-19 in patients with multiple sclerosis 3
Glucocorticoid-related genetic susceptibility for Alzheimer's disease 3
A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease 3
Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome 3
Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS 3
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience 3
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study 3
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 3
Analysis of cerebrospinal fluid IgA and IgG in patients with the Guillain-Barré syndrome | Analisi delle IgA e delle IgG liquorali in pazienti con sindrome di Guillain-Barré 3
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study 3
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 3
HTLV-I-associated myelopathy: Oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody 2
Pharmacogenomics of neurodegenerative diseases 2
Analysis of an IFN-γ gene (IFNG) polymorphism in multiple sclerosis in Europe: Effect of population structure on association with disease 2
IgG e IgA oligoclonali nella panencefalite sclerosante subacuta | Oligoclonal IgG and IgA in subacute sclerosing panencephalitis 2
Oligoclonal IgG bands in cerebrospinal fluid and serum during asympatomatic human immunodeficiency virus infection 2
Heterogeneity of autoantibodies in stiff-man syndrome 2
An association study on interleukin-1 β polymorphism in multiple sclerosis and Alzheimer's disease 2
Natalizumab therapy of multiple sclerosis: Recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society 2
A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects 2
Genetica e neurodegenerazione: nuove prospettive terapeutiche per il morbo di Alzheimer? 2
Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients 2
Does hemispheric dominance influence brain lesion distribution in multiple sclerosis? 2
Safety and efficacy of natalizumab in children with multiple sclerosis 2
The interleukin 1-β exonic (+3953) polymorphism does not alter in vitro protein secretion 2
Isoelectric focusing studies of serum and cerebrospinal fluid in patients with antecedent poliomyelitis 2
Soluble interleukin-1 receptor antagonist intron 2 polymorphism is associated with occurrence and clinical disability in patients with multiple sclerosis 2
Search for candidate genes in common migraine in the Italian population 2
Radiomics Analysis of Brain [18 F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 2
APOE -491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease 2
Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain 2
Effect of interferon gamma on T lymphocytes from patients with multiple sclerosis 2
Discontinuous distribution of IgG oligoclonal bands in cerebrospinal fluid from multiple sclerosis patients 2
Interferon-gamma induced increases in intracellular calcium in T lymphocytes from patients with multiple sclerosis precede clinical exacerbations and detection of active lesions on MRI 2
The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome in patients 2
Genetic heterogeneity in Italian families with familial hemiplegic migraine 2
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 2
Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic alzheimer's disease 2
Apolipoprotein E gene polymorphisms in patients with migraine 2
Rivastigmine may be helpful for the dementia of Parkinson's disease 2
Natalizumab in the pediatric MS population: Results of the Italian registry 2
Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness 2
Neuroinflammation and the genetics of Alzheimer's disease: The search for a pro-inflammatory phenotype 2
Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study 2
Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis 2
Identification of peptides binding to IgG in the CSF of multiple sclerosis patients 2
Totale 305
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025449 0 0 0 0 0 0 54 151 135 109 0 0
Totale 449